Skip to main content
Livermore
Livermore
ZHEN

Lord, Abbett & Co. LLC

SEC CIK
0000728100
Latest filing
Aug 14, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
166,581
Value
$82.7M
% of portfolio
0.2%
Quarters held
18
Since Q1 2021
Holdings of VRTX by Lord, Abbett & Co. LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026166,581$82.7M0.2%+720.0%AddedHolders
Q1 2026166,509$74.4M0.2%+166,509NewHolders
Q3 20250$00.0%−1,572−100.0%Sold outHolders
Q2 20251,572$700.0K<0.1%−1,375−46.7%ReducedHolders
Q1 20252,947$1.43M<0.1%−168−5.4%ReducedHolders
Q4 20243,115$1.25M<0.1%−164−5.0%ReducedHolders
Q3 20243,279$1.52M<0.1%+300+10.1%AddedHolders
Q2 20242,979$1.40M<0.1%−121,284−97.6%ReducedHolders
Q1 2024124,263$51.9M0.2%−2,312−1.8%ReducedHolders
Q4 2023126,575$51.5M0.2%−102,187−44.7%ReducedHolders
Q3 2023228,762$79.5M0.3%−1,806−0.8%ReducedHolders
Q2 2023230,568$81.1M0.3%+39,970+21.0%AddedHolders
Q1 2023190,598$60.1M0.2%−193,389−50.4%ReducedHolders
Q4 2022383,987$110.9M0.4%−170,599−30.8%ReducedHolders
Q3 2022554,586$160.6M0.6%+21,734+4.1%AddedHolders
Q2 2022532,852$150.2M0.5%−110,555−17.2%ReducedHolders
Q1 2022643,407$167.9M0.4%+643,407NewHolders
Q3 20210$00.0%−118,676−100.0%Sold outHolders
Q2 2021118,676$23.9M0.1%−6,729−5.4%ReducedHolders
Q1 2021125,405$26.9M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.